eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
4/2021
vol. 46
 
Share:
Send email
Share:
abstract:
Clinical immunology

Gender as a factor affecting NK cell activity in patients successfully treated for chronic hepatitis C with direct-acting antivirals

Agata Zientarska
1
,
Justyna Mikuła-Pietrasik
2
,
Mariusz Kaczmarek
3, 4, 5
,
Aleksandra Witkowska
1
,
Błażej Rozpłochowski
1
,
Arleta Kowala-Piaskowska
1
,
Krzysztof Książek
2
,
Jan Żeromski
3
,
Iwona Mozer-Lisewska
1

  1. Chair and Department of Infectious Diseases, Hepatology and Acquired Immunodeficiencies, Karol Marcinkowski University of Medical Sciences, Poznan, Poland
  2. Department of Pathophysiology of Ageing and Civilization Diseases, Karol Marcinkowski University of Medical , Poznan, Poland
  3. Chair of Clinical Immunology, Karol Marcinkowski University of Medical Sciences, Poznan, Poland
  4. Department of Cancer Immunology, Karol Marcinkowski University of Medical Sciences, Poznan, Poland
  5. Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, Poznan, Poland
(Cent Eur J Immunol 2021; 46 (4): 481-491)
DOI: https://doi.org/10.5114/ceji.2021.109846
Online publish date: 2021/12/06
View full text Get citation
 
PlumX metrics:
Chronic hepatitis C (CHC) affects the activity of natural killer (NK) cells, but successful interferon- free treatment partially restores it. The goal of this study was to assess whether gender influences NK functionality. We examined 21 post-menopausal women and 24 men with CHC who were treated with direct-acting antivirals (DAA) and 33 healthy volunteers. Using flow cytometry, we analysed KIR2DS4, NKG2D, NKp30, KIR2DL2/DL3, NKG2A and TRAIL on the surface of NK cells. Intracellular granzyme B was also assessed and serum CXCL10 was quantified via ELISA. Overall, patients with CHC had higher expression of KIR2DS4, NKG2A, and NKp30 relative to the control group. Further, CHC patients had a lower percentage of NK cells among lymphocytes relative to the control group. After treatment, KIR2DS4, KIR2DL2/DL, NKG2A, TRAIL and NKp30 on NK cells were decreased whilst the percentage of NK cells and the expression of granzyme B and NKG2D increased. Prior to treatment, serum CXCL10 was elevated, but it was inhibited post-treatment. We observed gender-specific differences in the expression of KIR2DL2/DL3 (higher in women) and NKp30 (elevated in men) compared to CHC/control groups. After treatment, KIR2DL2/DL3, NKp30 and CXCL10 dropped only in the female group while granzyme B increased in the male group. In conclusion, the response of NK cells among men and women of post-menopausal ages with CHC differs. Our research may lead to more studies on the different nature of female and male immune systems in the context of HCV infection and treatment.
keywords:

HCV, gender, NK cells, direct-acting antivirals
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.